| 000 | 01789 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515173403.0 | ||
| 264 | 0 | _c20091008 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1432-198X | ||
| 024 | 7 |
_a10.1007/s00467-009-1214-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAraya, Carlos | |
| 245 | 0 | 0 |
_aT regulatory cell function in idiopathic minimal lesion nephrotic syndrome. _h[electronic resource] |
| 260 |
_bPediatric nephrology (Berlin, Germany) _cSep 2009 |
||
| 300 |
_a1691-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Bispecific _ximmunology |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xdrug therapy |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukin-10 _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrosis, Lipoid _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aSuppressor Factors, Immunologic _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDiaz, Leila | |
| 700 | 1 | _aWasserfall, Clive | |
| 700 | 1 | _aAtkinson, Mark | |
| 700 | 1 | _aMu, Wei | |
| 700 | 1 | _aJohnson, Richard | |
| 700 | 1 | _aGarin, Eduardo | |
| 773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 24 _gno. 9 _gp. 1691-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00467-009-1214-x _zAvailable from publisher's website |
| 999 |
_c18920057 _d18920057 |
||